377 related articles for article (PubMed ID: 7802601)
41. [Adaptation of the oral dosage of theophylline to the asthmatic child. Value of a kinetic test by the intravenous route].
Albertini M; Lapalus P; Maurin S; Boutte P; Mariani R
Arch Fr Pediatr; 1982 Nov; 39(9):671-5. PubMed ID: 7165461
[TBL] [Abstract][Full Text] [Related]
42. [The usefulness of the bayesian method for the prediction of plasma theophylline levels in asthmatic children during RTC therapy by the sustained preparation of theophylline].
Okabe T; Hida M; Maruyama K; Kohgo T; Shibuya M; Ohashi A
Arerugi; 1994 Apr; 43(4):563-70. PubMed ID: 8031252
[TBL] [Abstract][Full Text] [Related]
43. [Serum theophylline levels after oral administration in a group of asthmatic children].
Escorihuela R; Llerena P; Royo F; Lillo Lillo M; de la Morena E; Borges Domingo T; López-Linares M
An Esp Pediatr; 1982 Dec; 17(6):461-5. PubMed ID: 7183217
[TBL] [Abstract][Full Text] [Related]
44. [Determination of theophylline serum level: comparison between a rapid test (enzyme-immuno-chromatography) and conventional fluorescence polarization immunoassay].
Mallin W; Eber E; Semmelrock HJ; Zach M
Pneumologie; 1990 Aug; 44(8):967-9. PubMed ID: 2217092
[TBL] [Abstract][Full Text] [Related]
45. [Studies of free theophylline in asthmatic patients].
Hattori H; Doi S; Yasunami J; Hayashida M; Inoue T; Takamatsu I; Toyoshima K; Kishimoto S
Arerugi; 1991 Jun; 40(6):597-604. PubMed ID: 1892441
[TBL] [Abstract][Full Text] [Related]
46. The relationship between pharmacodynamics and pharmacokinetics in asthmatic children receiving a sustained-release formulation of theophylline.
Schaefers M; Richter O; Reinhardt D; Becker B
Int J Clin Pharmacol Ther Toxicol; 1984 Aug; 22(8):406-15. PubMed ID: 6490223
[TBL] [Abstract][Full Text] [Related]
47. [Clinical effects of theophylline in the therapy of intractable asthmatic children. I. Clinical effects of a new sustained-release preparation of theophylline E-0686].
Segawa H; Uematsu F; Iikura Y
Arerugi; 1987 Jan; 36(1):38-48. PubMed ID: 3592990
[No Abstract] [Full Text] [Related]
48. Serum theophylline levels in adult asthmatics: comparison of oral sustained-release and microcrystalline preparations.
Jones DT; Sears MR
N Z Med J; 1980 Sep; 92(667):196-8. PubMed ID: 6933358
[TBL] [Abstract][Full Text] [Related]
49. [Theophylline concentration in the blood of children with persistently recurring bronchial asthma].
Gusel' VA; Zisel'son AD; Verbov VN; Gorshkova IuG
Farmakol Toksikol; 1986; 49(5):29-31. PubMed ID: 3770170
[TBL] [Abstract][Full Text] [Related]
50. [Clinical effects of theophylline in the therapy of intractable asthmatic children. II. Theophylline therapy and behavior problems in children with asthma].
Segawa H; Iikura Y
Arerugi; 1990 Oct; 39(10):1427-36. PubMed ID: 2124479
[TBL] [Abstract][Full Text] [Related]
51. [Therapeutic and toxic theophylline levels in asthma attacks--is there a need for additional theophylline?].
Zeidman A; Gardyn J; Fradin Z; Fink G; Mittelman M
Harefuah; 1997 Jul; 133(1-2):3-5, 80. PubMed ID: 9332046
[TBL] [Abstract][Full Text] [Related]
52. [Examination of theophylline pharmacokinetics during an attack of bronchial asthma in children].
Odajima Y
Arerugi; 1992 Jan; 41(1):22-8. PubMed ID: 1554321
[TBL] [Abstract][Full Text] [Related]
53. [The effect of 6 week treatment with theophylline on spirometric parameters, nonspecific bronchial reactivity and the concentration of soluble interleukin 2 receptor in serum of asthmatic patients].
Wrońska J; Mazurek J; Chazan R; Grubek-Jaworska H; Droszcz W
Wiad Lek; 2000; 53(3-4):164-9. PubMed ID: 10946603
[TBL] [Abstract][Full Text] [Related]
54. Efficacy and safety of intravenous theophylline administration for treatment of mild acute exacerbation of bronchial asthma.
Yamauchi K; Kobayashi H; Tanifuji Y; Yoshida T; Pian HD; Inoue H
Respirology; 2005 Sep; 10(4):491-6. PubMed ID: 16135173
[TBL] [Abstract][Full Text] [Related]
55. [Analysis of the theophylline pharmacokinetics of sustained-release theophylline (Theodur) dry syrup in children].
Okuma M; Iikura Y
Arerugi; 1999 Jun; 48(6):589-96. PubMed ID: 10423899
[TBL] [Abstract][Full Text] [Related]
56. [Inhibition of growth hormone secretion by theophylline in asthmatic children].
Baum WF; Klöditz E; Schneyer U
Pneumologie; 1996 Mar; 50(3):238-41. PubMed ID: 8919920
[TBL] [Abstract][Full Text] [Related]
57. Plasma theophylline concentrations in asthmatic children receiving a twice daily theophylline preparation.
Teo J; Lee HS; Teo PC
Singapore Med J; 1986 Jun; 27(3):210-3. PubMed ID: 3764456
[No Abstract] [Full Text] [Related]
58. Bioavailability, efficacy, and tolerance of two sustained-release theophylline dosage forms in adult patients with bronchial asthma.
Trautlein JJ; Demers L; Esler V; Field E
Clin Ther; 1981; 4(4):252-62. PubMed ID: 7332913
[TBL] [Abstract][Full Text] [Related]
59. [Bronchial asthma: use of combination therapy. Anti-obstructive and anti-inflammatory treatment--result of treatment].
Zahn T
Fortschr Med; 1994 Apr; 112(11):161-2. PubMed ID: 8200600
[TBL] [Abstract][Full Text] [Related]
60. Oral fenoterol versus sustained release theophylline in adult asthmatics.
Lucena MI; Almagro J; Andrade RJ; Hidalgo Sanchez R; Sanchez de la Cuesta F
Int J Clin Pharmacol Ther; 1997 Jan; 35(1):19-23. PubMed ID: 9021437
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
